1-9 of 9
Erika M. Gaglione
Close
Sort by
Journal Articles

BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL

Maissa Mhibik, Erika M. Gaglione, David Eik, Ellen K. Kendall, Amy Blackburn, Keyvan Keyvanfar, Maria Joao Baptista, Inhye E. Ahn, Clare Sun, Junpeng Qi, Christoph Rader, Adrian Wiestner
Journal: Blood
Blood (2021) 138 (19): 1843–1854.
https://doi.org/10.1182/blood.2020009686
Published: 2021
Includes: Supplemental data
Journal Articles

Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL

Clare Sun, Erika M Gaglione, Lauren T Vaughn, Rui Mu, Chingiz Underbayev, Jonathan Chen, Christopher Pleyer, Adrian Wiestner
Journal: Blood
Blood (2021) 138 (Supplement 1): 3724.
https://doi.org/10.1182/blood-2021-148887
Published: 2021
Journal Articles

Effect of Bruton Tyrosine Kinase Inhibitor on Serologic and Cellular Immune Responses to Recombinant Zoster Vaccine

Christopher Pleyer, Kerry J Laing, Mir Ali, Christopher L McClurkan, Susan Soto, Inhye E. Ahn, Pia Nierman, Emeline Maddux, Jennifer Lotter, Jeanine Superata, Xin Tian, Erika M Gaglione, Adrian Wiestner, Jeffrey Cohen, David M Koelle, Clare Sun
Journal: Blood
Blood (2021) 138 (Supplement 1): 1556.
https://doi.org/10.1182/blood-2021-148539
Published: 2021
Journal Articles

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Clinical Trials & Observations Brief Report
Christopher Pleyer, Mir A. Ali, Jeffrey I. Cohen, Xin Tian, Susan Soto, Inhye E. Ahn, Erika M. Gaglione, Pia Nierman, Gerald E. Marti, Charles Hesdorffer, Jennifer Lotter, Jeanine Superata, Adrian Wiestner, Clare Sun
Journal: Blood
Blood (2021) 137 (2): 185–189.
https://doi.org/10.1182/blood.2020008758
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Clinical Trials & Observations
Clare Sun, Pia Nierman, Ellen K. Kendall, Jean Cheung, Michael Gulrajani, Sarah E. M. Herman, Christopher Pleyer, Inhye E. Ahn, Maryalice Stetler-Stevenson, Constance M. Yuan, Irina Maric, Erika M. Gaglione, Hailey M. Harris, Stefania Pittaluga, Min Hui Wang, Priti Patel, Mohammed Z. H. Farooqui, Raquel Izumi, Ahmed Hamdy, Todd Covey, Adrian Wiestner
Journal: Blood
Blood (2020) 136 (1): 93–105.
https://doi.org/10.1182/blood.2019003715
Published: 2020
Includes: Supplemental data
Journal Articles

Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells

Maria Joao Baptista, PhD PharmD, Sivasubramanian Baskar, Keyvan Keyvanfar, Erika M Gaglione, Inhye E Ahn, MD, Adrian Wiestner, MD PhD, Clare Sun, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3030.
https://doi.org/10.1182/blood-2019-127131
Published: 2019
Journal Articles

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Maissa Mhibik, PhD, Erika M Gaglione, Amy Blackburn, Keyvan Keyvanfar, Clare Sun, MD, Inhye E Ahn, MD, Maria Joao Baptista, Junpeng Qi, PhD, Christoph Rader, PhD, Adrian Wiestner, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2861.
https://doi.org/10.1182/blood-2019-126186
Published: 2019
Journal Articles

Risk-Adapted, Ofatumumab-Based Chemoimmunotherapy and Maintenance in Treatment-Naïve CLL: A Phase II Study

Sanjal Desai, MD, Dennis Drinkwater, Clifton Craig Mo, MD, Mohammed ZH Farooqui, Susan Soto, Janet Valdez, Erika M Gaglione, Xin Tian, Pia Nierman, Jennifer Lotter, PA-C, Gerald Marti, Cydney Nichols, BS, Alankrita Taneja, MD, Sarah E. M. Herman, PhD, Irina Maric, MD MSci, Laura M Wake, MD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Tom Hughes, Pharm.D., Margaret A. Lindorfer, Ronald P. Taylor, Adrian Wiestner, MD PhD, Inhye E Ahn, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5474.
https://doi.org/10.1182/blood-2019-126698
Published: 2019
Journal Articles

Diverging Clonal Evolution during Sequential Therapy with Chemoimmunotherapy Followed By BTK Inhibitors

Inhye E Ahn, MD, Yun-Ching Chen, PhD, Chingiz Underbayev, MD PhD, Erika M Gaglione, Clare Sun, MD, Susan Soto, Pia Nierman, Mehdi Pirooznia, MD PhD, Adrian Wiestner, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 850.
https://doi.org/10.1182/blood-2019-122142
Published: 2019